Problem-Solving for Rural Heart Failure Dyads

April 10, 2023 updated by: Lucinda Graven, Florida State University

Enhancing Problem-Solving Skills in Underserved Rural Heart Failure Dyads

This study will develop and test the effectiveness of a culturally-sensitive, telephone-based, tailored dyadic problem-solving intervention to improve self-care in rural heart failure (HF) dyads. The target population is rural-residing HF dyads (patient and family caregiver). Rural dyads will be recruited from the Florida State University Institute for Successful Longevity Participant Registry, outpatient HF/cardiac and rural healthcare clinics affiliated with the Tallahassee Memorial Hospital, Bond Community Health Clinic, via social medial and newspaper ads, and publicly available community sites (e.g., senior centers, post offices, grocery stores, etc.). Phase I (Arm I) will include a one-time telephone-based semi-structured interview. Dyads in Phase II (Arm II) will receive one telehealth (virtual or telephone) session, followed by 7 follow-up telephone sessions.

Study Overview

Status

Completed

Conditions

Detailed Description

The long-term goal of this research is to reduce morbidity and improve HF self-care by enhancing family problem-solving and collaborative care management among rural HF dyads. The initial step in meeting this goal is to develop and pilot-test a culturally-sensitive, telephone-based, tailored dyadic problem-solving intervention to improve HF self-care in rural HF dyads. Using a multi-phase, sequential qualitative and quantitative approach, the following research aims are to: 1) identify the major dyadic HF-related problems dyads experience and how these problems are managed; 2) develop a telephone-based, tailored dyadic problem-solving intervention and determine its feasibility and acceptability for managing HF-related problems; and 3) evaluate the preliminary effects of the telephone-based, tailored dyadic problem-solving intervention on dyadic problem-solving and patient and family caregiver contributions to HF self-care. As an exploratory aim, we will also evaluate the effectiveness of the dyadic problem-solving intervention on caregiver burden, self-care, and life changes. In Phase I, qualitative inquiry will guide in-depth semi-structured dyad interviews (n = 12-20 dyads; 24-40 participants) to identify the dyadic HF-related problems experienced by rural HF dyads and associated management strategies (Aim 1). Phase II will be guided by qualitative and quantitative methods and include a repeated measures, single-group design to evaluate the feasibility, acceptability, and preliminary effectiveness of the 12-week dyadic problem-solving intervention in a sample of rural HF dyads (n = 60 dyads; 120 participants) (Aims 2, 3). Participants for this study will be recruited from from the Florida State University Institute for Successful Longevity Participant Registry, outpatient HF/cardiac and rural healthcare clinics affiliated with Tallahassee Memorial Hospital, Bond Community Health Clinic, via social medial and newspaper ads, and publicly available community sites (e.g., senior centers, post offices, grocery stores, etc.).

Phase I (Arm 1) will identify dyadic HF-related problems and management strategies using semi-structured interviews in a sample of rural-residing HF dyads (n = 12-20 dyads; 24-40 participants). Following consent, interviews will occur once and be approximately 45 minutes long. Qualitative data from Phase I will be analyzed using thematic analytic methods and NVivo11. Information gained in Phase I will be used to develop the telephone-based, tailored, dyadic problem-solving intervention for rural HF dyads tested in Phase II.

Phase II (Arm II) will be guided by qualitative and quantitative inquiry and include a single-group, repeated measures design with time and dyad-member as within-subject factors. A sample size of 60 dyads (120 participants) is desired based on a power analysis for repeated measures ANOVA with 4 time points, alpha level of .05, a medium effect size (f = 0.25), and 80% power, plus oversampling for potential attrition (20%). Following verbal informed consent via telephone, all dyads will be screened for cognitive impairment using the Telephone Interview for Cognitive Status (TICS) prior to baseline data collection, which will include a Sociodemographic and Clinical Survey, the Self-Care of HF Index (SCHFI; v. 6.2) (patients only), the Caregiver Contribution to the Self-Care of HF Index (CCSCHFI) (caregivers only), Healthcare Utilization Survey, the Social Problem-Solving Inventory Revised-Short (SPSIRS), the Center for Epidemiological Studies-Depression (CESD), the Global Family Function Subscale (GFF) of the Family Assessment Device Questionnaire, and the Interpersonal Support Evaluation List-12 (ISEL-12). Caregivers will also complete the Dutch Objective Burden Inventory (DOBI), Denyes Self-care Practice Instrument (DENYES), and the BAKAS Caregiving Outcomes Scale (BAKAS).

Using a single group design, all dyads will participate in a problem-solving training intervention over 12 weeks (Weeks 1-4, 6, 8, 10, 12), with follow-up data collection occurring at weeks 5, 9, 11, 13. Qualitative data will be collected at weeks 5 and 11 via semi-structured interviews with dyads. Quantitative data on study outcomes and covariates will be collected at weeks 5, 9, and 13 and consist of the SCHFI (patient), CCSCHFI (caregiver), healthcare utilization (patient), SPSIRS (dyad), REALM (dyad), CESD (dyad), GFF (dyad),ISEL-12 (dyad), DOBI (caregiver), Denyes (caregiver) and the BAKAS (caregiver). All data will be self-report and collected by a trained research assistant who will collect study data over the telephone and mark participants answers on a computerized data spreadsheet. Qualitative data will be analyzed using thematic analytic methods and NVivo11. Possible treatment effectiveness on dyadic problem-solving, patient and caregiver contributions to HF self-care, healthcare utilization, caregiver burden, caregiver self-care, caregiver life changes, and differences among subgroups (gender, relationship type) over the 13 weeks will be examined using multilevel modeling and dyadic Growth Curve Modeling (GCM).

Study Type

Interventional

Enrollment (Actual)

94

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Lucinda J Graven, PhD APRN
  • Phone Number: 850-644-5601
  • Email: lgraven@fsu.edu

Study Locations

    • Florida
      • Blountstown, Florida, United States, 32424
        • Tallahassee Memorial Hospital Physician Partners - Blountstown Clinic
      • Crawfordville, Florida, United States, 32327
        • Tallahassee Memorial Hospital Physician Partners - Wakulla Clinic
      • Marianna, Florida, United States, 32446
        • Talllahassee Memorial Physician Partners Cardiology - Marianna Clinic
      • Monticello, Florida, United States, 32344
        • Tallahassee Memorial Hospital Physician Partners - Monticello Clinic
      • Perry, Florida, United States, 32347
        • Tallahassee Memorial Hospital Physician Partners - Perry Clinic
      • Quincy, Florida, United States, 32351
        • Tallahassee Memorial Hospital Physician Partners - Quincy Clinic
      • Tallahassee, Florida, United States, 32301
        • Bond Community Health Center
      • Tallahassee, Florida, United States, 32308
        • Tallahassee Memorial Hospital Physician Partners Cardiology Heart Failure Clinic
      • Tallahassee, Florida, United States, 32324
        • HCA Capital Cardiology Associates

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • ≥ 18 years of age
  • consist of a patient with New York Heart Association Class II- IV HF and their family caregiver
  • live in a rural area
  • read, write, and communicate verbally in English
  • have access to a telephone with speaker capability
  • family caregivers are defined as a spouse/partner or adult family member living in the same household and/or considered to be the primary caregiver and may be healthy

Exclusion Criteria:

  • patient has HF due to a correctable cause or condition
  • either dyad member exhibits cognition dysfunction (i.e., score ≤ 30 on the Telephone Interview for Cognitive Status [TICS])

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Phase I: Qualitative
Rural HF dyads will participate in a one-time telephone-based semi-structured interview to explore the types of HF-related problems that rural HF dyads experience and how these problems are managed.
Experimental: Phase II: Problem-Solving for Rural HF Dyads
The dyadic problem-solving intervention will be provided by a HF specialist nurse. The nurse will conduct the initial telehealth (virtual, telephone) session and provide dyads with an intervention booklet containing examples of common HF-related problems experienced by rural dyads and suggested management strategies tailored to the rural sociocultural context. The nurse will lead dyads in a card sorting task intended to help dyads prioritize current HF-related problems and will guide dyads in developing management strategies for the highest priority problem. Dyads will utilize these strategies until the next session at which time the nurse will guide dyads in evaluating the effectiveness of chosen strategies. The iterative process then begins again. Dyads will receive 7 follow-up telephone sessions with the nurse. In the intervention, the nurse will focus on problems related to self-care, including those specific to the rural population.
Participants in the Intervention Group will be trained to use a 4-step problem-solving process based on the Theory of Social Problem-Solving (TSPS) to manage HF-related problems collaboratively over 12-weeks. The core belief of TSPS is effective problem-solving requires a positive problem orientation (i.e., viewing problems as a challenge versus a threat) and elicits rational problem-solving versus avoidance or impulsivity/carelessness. Dyadic problem-solving follows from a positive problem orientation and involves accurate problem identification, generation of appropriate potential solutions, active decision-making, and solution implementation and evaluation. The goal of this dyadic intervention is to move HF dyads toward a positive problem orientation and use of rational problem-solving strategies that support greater patient and family caregiver-contributed HF self-care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Care Maintenance (HF patient)
Time Frame: Baseline, 5 weeks
Self-care maintenance will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to treatment adherence and self-monitoring. Scores are standardized (0-100), with higher scores suggesting better self-care maintenance. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
Baseline, 5 weeks
Self-Care Maintenance (HF patient)
Time Frame: Baseline, 9 weeks
Self-care maintenance will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to treatment adherence and self-monitoring. Scores are standardized (0-100), with higher scores suggesting better self-care maintenance. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
Baseline, 9 weeks
Self-Care Maintenance (HF patient)
Time Frame: Baseline, 13 weeks
Self-care maintenance will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to treatment adherence and self-monitoring. Scores are standardized (0-100), with higher scores suggesting better self-care maintenance. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
Baseline, 13 weeks
Self-Care Management (HF patient)
Time Frame: Baseline, 5 weeks
Self-care management will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to symptom recognition and treatment and evaluation of treatment effectiveness. Scores are standardized (0-100), with higher scores suggesting better self-care management. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
Baseline, 5 weeks
Self-Care Management (HF patient)
Time Frame: Baseline, 9 weeks
Self-care management will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to symptom recognition and treatment and evaluation of treatment effectiveness. Scores are standardized (0-100), with higher scores suggesting better self-care management. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
Baseline, 9 weeks
Self-Care Management (HF patient)
Time Frame: Baseline, 13 weeks
Self-care management will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to symptom recognition and treatment and evaluation of treatment effectiveness. Scores are standardized (0-100), with higher scores suggesting better self-care management. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
Baseline, 13 weeks
Self-Care Confidence (HF patient)
Time Frame: Baseline, 5 weeks
Self-care confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to one's confidence in their ability to perform self-care activities. Scores are standardized (0-100), with higher scores suggesting better self-care confidence. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
Baseline, 5 weeks
Self-Care Confidence (HF patient)
Time Frame: Baseline, 9 weeks
Self-care confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to one's confidence in their ability to perform self-care activities. Scores are standardized (0-100), with higher scores suggesting better self-care confidence. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
Baseline, 9 weeks
Self-Care Confidence (HF patient)
Time Frame: Baseline, 13 weeks
Self-care confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to one's confidence in their ability to perform self-care activities. Scores are standardized (0-100), with higher scores suggesting better self-care confidence. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
Baseline, 13 weeks
Caregiver Contribution to Self-Care Maintenance (caregiver)
Time Frame: Baseline, 5 weeks
Caregiver contribution to self-care maintenance will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI). Items pertain to one's contribution to treatment adherence and symptom monitoring. Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care maintenance.
Baseline, 5 weeks
Caregiver Contribution to Self-Care Maintenance (caregiver)
Time Frame: Baseline, 9 weeks
Caregiver contribution to self-care maintenance will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI). Items pertain to one's contribution to treatment adherence and symptom monitoring. Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care maintenance.
Baseline, 9 weeks
Caregiver Contribution to Self-Care Maintenance (caregiver)
Time Frame: Baseline, 13 weeks
Caregiver contribution to self-care maintenance will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI). Items pertain to one's contribution to treatment adherence and symptom monitoring. Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care maintenance.
Baseline, 13 weeks
Caregiver Contribution to Self-Care Management (caregiver)
Time Frame: Baseline, 5 weeks
Caregiver contribution to self-care management will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI). Items pertain to one's contribution to symptom recognition and treatment and evaluation of treatment effectiveness. Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care management.
Baseline, 5 weeks
Caregiver Contribution to Self-Care Management (caregiver)
Time Frame: Baseline, 9 weeks
Caregiver contribution to self-care management will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI). Items pertain to one's contribution to symptom recognition and treatment and evaluation of treatment effectiveness. Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care management.
Baseline, 9 weeks
Caregiver Contribution to Self-Care Management (caregiver)
Time Frame: Baseline, 13 weeks
Caregiver contribution to self-care management will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI). Items pertain to one's contribution to symptom recognition and treatment and evaluation of treatment effectiveness. Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care management.
Baseline, 13 weeks
Caregiver Contribution to Self-Care Confidence (caregiver)
Time Frame: Baseline, 5 weeks
Caregiver contribution to self-care confidence will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI). Items pertain to one's contribution to confidence in self-care ability. Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care confidence.
Baseline, 5 weeks
Caregiver Contribution to Self-Care Confidence (caregiver)
Time Frame: Baseline, 9 weeks
Caregiver contribution to self-care confidence will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI). Items pertain to one's contribution to confidence in self-care ability. Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care confidence.
Baseline, 9 weeks
Caregiver Contribution to Self-Care Confidence (caregiver)
Time Frame: Baseline, 13 weeks
Caregiver contribution to self-care confidence will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI). Items pertain to one's contribution to confidence in self-care ability. Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care confidence.
Baseline, 13 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healthcare Utilization (patient)
Time Frame: baseline, 5 weeks
Healthcare utilization will be determined by the frequency of emergency department visits and 30-day readmissions for HF and assessed via self-report.
baseline, 5 weeks
Healthcare Utilization (patient)
Time Frame: baseline, 9 weeks
Healthcare utilization will be determined by the frequency of emergency department visits and 30-day readmissions for HF and assessed via self-report.
baseline, 9 weeks
Healthcare Utilization (patient)
Time Frame: baseline, 13 weeks
Healthcare utilization will be determined by the frequency of emergency department visits and 30-day readmissions for HF and assessed via self-report.
baseline, 13 weeks
Problem-Solving (HF patient and caregiver)
Time Frame: baseline, 5 weeks
Problem-solving will be self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style. In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style. Higher scores on each sub-scale suggest more of the problem-solving characteristic. Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
baseline, 5 weeks
Problem-Solving (HF patient and caregiver)
Time Frame: baseline, 9 weeks
Problem-solving will be self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style. In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style. Higher scores on each sub-scale suggest more of the problem-solving characteristic. Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
baseline, 9 weeks
Problem-Solving (HF patient and caregiver)
Time Frame: baseline,13 weeks
Problem-solving will be self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style. In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style. Higher scores on each sub-scale suggest more of the problem-solving characteristic. Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
baseline,13 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression (patient and caregiver)
Time Frame: baseline, 5 weeks
Depression will be self-reported and assessed using the 20-item Center for Epidemiological Studies-Depression Scale (CES-D). The CES-D measures the presence of depression. Scores range from 0-60, with higher scores indicative of more symptoms of depression. A cut-off score ≥ 16 indicates depressed versus non-depressed.
baseline, 5 weeks
Depression (patient and caregiver)
Time Frame: baseline, 9 weeks
Depression will be self-reported and assessed using the 20-item Center for Epidemiological Studies-Depression Scale (CES-D). The CES-D measures the presence of depression. Scores range from 0-60, with higher scores indicative of more symptoms of depression. A cut-off score ≥ 16 indicates depressed versus non-depressed.
baseline, 9 weeks
Depression (patient and caregiver)
Time Frame: baseline, 13 weeks
Depression will be self-reported and assessed using the 20-item Center for Epidemiological Studies-Depression Scale (CES-D). The CES-D measures the presence of depression. Scores range from 0-60, with higher scores indicative of more symptoms of depression. A cut-off score ≥ 16 indicates depressed versus non-depressed.
baseline, 13 weeks
Family Function (patient and caregiver)
Time Frame: baseline, 5 weeks
Family function will be self-reported and measured using the Global Family Function (GFF) Subscale of the Family Assessment Device Questionnaire (12-items.The GFF assesses perception of overall family health related to problem-solving, communication, roles, active responses, affective involvement, and behavior control. Final mean scores range from 1 to 4 (healthy to unhealthy family functioning).
baseline, 5 weeks
Family Function (patient and caregiver)
Time Frame: baseline, 9 weeks
Family function will be self-reported and measured using the Global Family Function (GFF) Subscale of the Family Assessment Device Questionnaire (12-items.The GFF assesses perception of overall family health related to problem-solving, communication, roles, active responses, affective involvement, and behavior control. Final mean scores range from 1 to 4 (healthy to unhealthy family functioning).
baseline, 9 weeks
Family Function (patient and caregiver)
Time Frame: baseline, 13 weeks
Family function will be self-reported and measured using the Global Family Function (GFF) Subscale of the Family Assessment Device Questionnaire (12-items.The GFF assesses perception of overall family health related to problem-solving, communication, roles, active responses, affective involvement, and behavior control. Final mean scores range from 1 to 4 (healthy to unhealthy family functioning).
baseline, 13 weeks
Social Support (patient and caregiver)
Time Frame: baseline, 5 weeks
Social support will be self-reported and assessed using the Interpersonal Support and Evaluation List - 12 (ISEL-12) which measures perceived belonging, tangible, and appraisal support. Scores range from 0-36, with higher scores suggesting a higher perception of available support.
baseline, 5 weeks
Social Support (patient and caregiver)
Time Frame: baseline, 9 weeks
Social support will be self-reported and assessed using the Interpersonal Support and Evaluation List - 12 (ISEL-12) which measures perceived belonging, tangible, and appraisal support. Scores range from 0-36, with higher scores suggesting a higher perception of available support.
baseline, 9 weeks
Social Support (patient and caregiver)
Time Frame: baseline, 13 weeks
Social support will be self-reported and assessed using the Interpersonal Support and Evaluation List - 12 (ISEL-12) which measures perceived belonging, tangible, and appraisal support. Scores range from 0-36, with higher scores suggesting a higher perception of available support.
baseline, 13 weeks
Caregiver Burden (caregiver)
Time Frame: baseline, 5 weeks
Caregiver burden will be self-reported and assessed using the Dutch Objective Burden Inventory (DOBI), which measures both objective and subjective burden. Responses for each item range from 1 (no, never, not at all burdensome) to 3 (yes, often or always, very burdensome), with total scores on each subscale ranging from 1-3. Higher scores indicate greater perceived objective and subjective burden.
baseline, 5 weeks
Caregiver Burden (caregiver)
Time Frame: baseline, 9 weeks
Caregiver burden will be self-reported and assessed using the Dutch Objective Burden Inventory (DOBI), which measures both objective and subjective burden. Responses for each item range from 1 (no, never, not at all burdensome) to 3 (yes, often or always, very burdensome), with total scores on each subscale ranging from 1-3. Higher scores indicate greater perceived objective and subjective burden.
baseline, 9 weeks
Caregiver Burden (caregiver)
Time Frame: baseline, 13 weeks
Caregiver burden will be self-reported and assessed using the Dutch Objective Burden Inventory (DOBI), which measures both objective and subjective burden. Responses for each item range from 1 (no, never, not at all burdensome) to 3 (yes, often or always, very burdensome), with total scores on each subscale ranging from 1-3. Higher scores indicate greater perceived objective and subjective burden.
baseline, 13 weeks
Caregiver Self-care (caregiver)
Time Frame: baseline, 5 weeks
Caregiver self-care will be measured using the 18-item Denyes Self-care Practice Instrument (DENYES) which measures self-care activities that are universal self-care requisites (e.g., diet, rest, exercise, etc.). Response options for each item range from 0 to 156, with a total score calculated by averaging the time responses for all behaviors, with higher scores representing better self-care.
baseline, 5 weeks
Caregiver Self-care (caregiver)
Time Frame: baseline, 9 weeks
Caregiver self-care will be measured using the 18-item Denyes Self-care Practice Instrument (DENYES) which measures self-care activities that are universal self-care requisites (e.g., diet, rest, exercise, etc.). Response options for each item range from 0 to 156, with a total score calculated by averaging the time responses for all behaviors, with higher scores representing better self-care.
baseline, 9 weeks
Caregiver Self-care (caregiver)
Time Frame: baseline, 13 weeks
Caregiver self-care will be measured using the 18-item Denyes Self-care Practice Instrument (DENYES) which measures self-care activities that are universal self-care requisites (e.g., diet, rest, exercise, etc.). Response options for each item range from 0 to 156, with a total score calculated by averaging the time responses for all behaviors, with higher scores representing better self-care.
baseline, 13 weeks
Life Changes (caregiver)
Time Frame: baseline, 5 weeks
Caregiving-related life changes will be measured using the 15-item Bakas Caregiving Outcomes Scale. This instrument measures care partners' perceptions of how caregiving has influenced their social functioning, subjective well-being, and physical health using a 7-point (-3 [1] to +3 [7]) Likert-type scale. Total scores range from 15 to 105, with higher scores indicating more positive caregiving-related life changes.
baseline, 5 weeks
Life Changes (caregiver)
Time Frame: baseline, 9 weeks
Caregiving-related life changes will be measured using the 15-item Bakas Caregiving Outcomes Scale. This instrument measures care partners' perceptions of how caregiving has influenced their social functioning, subjective well-being, and physical health using a 7-point (-3 [1] to +3 [7]) Likert-type scale. Total scores range from 15 to 105, with higher scores indicating more positive caregiving-related life changes.
baseline, 9 weeks
Life Changes (caregiver)
Time Frame: baseline, 13 weeks
Caregiving-related life changes will be measured using the 15-item Bakas Caregiving Outcomes Scale. This instrument measures care partners' perceptions of how caregiving has influenced their social functioning, subjective well-being, and physical health using a 7-point (-3 [1] to +3 [7]) Likert-type scale. Total scores range from 15 to 105, with higher scores indicating more positive caregiving-related life changes.
baseline, 13 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 29, 2020

Primary Completion (Actual)

March 13, 2023

Study Completion (Actual)

March 13, 2023

Study Registration Dates

First Submitted

September 9, 2020

First Submitted That Met QC Criteria

September 14, 2020

First Posted (Actual)

September 16, 2020

Study Record Updates

Last Update Posted (Actual)

April 11, 2023

Last Update Submitted That Met QC Criteria

April 10, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 00001621

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No IPD will be shared with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

3
Subscribe